Prophylactic vs Therapeutic Cerebrospinal Fluid Drain Placement During Endovascular Thoracoabdominal Aortic Aneurysm Repair
Spinal Cord Ischemia
About this trial
This is an interventional prevention trial for Spinal Cord Ischemia
Eligibility Criteria
Inclusion Criteria:
- Age ≥18
- Undergoing high risk endovascular thoraco-abdominal aortic aneurysm repair, based on aortic coverage length:
2a: Extent I, II, III TAAA 2b: Extent IV TAAA with >5cm coverage above the celiac artery
Exclusion Criteria:
- Active prison incarceration
- active pregnancy
- moribund patients
- ruptured aneurysm
- coagulopathy precluding CSF drain placement
- urgent or emergent aneurysm repairs
Sites / Locations
- Univeristy of Alabama at Birmingham HospitalRecruiting
- UMass Memorial Health HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Prophylactic cerebrospinal fluid drain placement
Selective cerebrospinal fluid drain placement
Patients randomized to receive the experimental treatment will have a prophylactic cerebrospinal fluid drain placed prior to their endovascular aortic repair. All components of the endovascular aortic repair are standard of care treatments.
Patients randomized to the control arm of the study will not receive a prophylactic cerebrospinal fluid drain prior to their endovascular aortic repair. Patients will receive a CSF drain post-operative as needed to treat any symptoms of spinal cord ischemia. This arm of the study is current standard of care.